Efficient Drug Development

TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

Do you want to exchange knowledge?

Steven Erpelinck is happy to talk to you.

Contact me

Our latest developments

3 resultaten, getoond 1 t/m 3

Sex hormones determine the risk of liver damage in children with overweight

Informatietype:
News
28 July 2026
Research by Maastricht UMC+ and TNO shows that oestradiol protects against liver damage, while androgens such as testosterone are associated with an increased risk, in both girls and boys.
Read more
over Sex hormones determine the risk of liver damage in children with overweight

TNO launches Peregrion to boost market impact of its technology that accelerates medicine development

Informatietype:
News
25 March 2024
Read more
over TNO launches Peregrion to boost market impact of its technology that accelerates medicine development

TNO and Janssen sign intention to develop new collaborations

Informatietype:
News
16 December 2020
Read more
over TNO and Janssen sign intention to develop new collaborations